Kathy Neuzil Academiccv July2014
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
The Typhoid Vaccine Acceleration Consortium
Vaccine 35 (2017) 5081–5088 Contents lists available at ScienceDirect Vaccine journal homepage: www.elsevier.com/locate/vaccine Conference report The Typhoid Vaccine Acceleration Consortium (TyVAC): Vaccine effectiveness study designs: Accelerating the introduction of typhoid conjugate vaccines and reducing the global burden of enteric fever. Report from a meeting held on 26–27 October 2016, Oxford, UK ⇑ James E. Meiring a, , Malick Gibani a, the TyVAC Consortium Meeting Group: Buddha Basnyat a,b, Adwoa D. Bentsi-Enchill c, John Clemens d, Thomas C. Darton e,f, Kashmira Date g, Gordon Dougan h, Denise Garrett i, Bradford D. Gessner j, Melita A. Gordon k,l, Robert S. Heyderman m, Joachim Hombach c, Karen L. Kotloff n, Myron M. Levine n, Stephen P. Luby o, Vadrevu Krishna Mohan p, Anthony A. Marfin q, Kim Mulholland r, Kathleen Neuzil n, Virginia E. Pitzer s, Andrew J. Pollard e, Firdausi Qadri d, David Salisbury t, Anita Zaidi u a Oxford University Clinical Research Unit, Patan Academy of Health Sciences, Kathmandu, Nepal b Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, United Kingdom c Department of Immunization, Vaccines and Biologicals, World Health Organization, Geneva, Switzerland d International Centre for Diarrhoeal Diseases Research, Bangladesh (icddr,b), Dhaka, Bangladesh e Oxford Vaccine Group, Department of Paediatrics, University of Oxford, and the NIHR Oxford Biomedical Research Centre, Oxford, United Kingdom f The Hospital for Tropical Diseases, Wellcome Trust Major Overseas -
MEDICINE Buspring 2020 • Volume 104Et • Number 4 In
MEDICINE BuSpring 2020 • Volume 104et • Number 4 in THE GREATEST GOOD Maryland’s Center for Vaccine Development Innovations in Renal Transplantation Advancing the Field of Transplantation University of Maryland Medical Center Division of Transplantation recently concluded an eight-year study on the benefits of combining living donor kidney transplantation and panniculectomy. Guidelines suggest those with body mass index (BMI) >40 are less likely to benefit from transplantation. While nearly a quarter of those on the waiting list are categorized as obese, only 15% of renal transplants occur in obese patients. Obese and post-obese patients often have a large abdominal pannus, which may be prohibitive to transplantation. By using a multidisciplinary team to combine living donor renal transplant and panniculectomy, UMMC was able to greatly improve access to transplantation for the obese and post-obese population. This combined approach, unique to UMMC, yielded shorter- than-expected hospital stays and patients experienced excellent postoperative outcomes, and thus should be considered for patients in whom transplantation might otherwise be withheld on the basis of obesity. Transplant surgeons at UMMC prepare a living kidney donation for transplantation. Improving access to To refer a patient or consult with one of our physicians call 410-328-5408 transplantation Superior surgical Learn more at umm.edu/transplant expertise Visit our Physician Video Channel at physicians.umm.edu MEDICINE Bulletin Editorial Board Harry C. Knipp, ’76 Chairman Gary D. Plotnick, ’66 Vice Chairman John Allen, ’14 Frank M. Calia, MD, MACP Bu etin Triesta Fowler-Lee, ’99 Nidhi Goel, ’10 Christopher Hardwick Sachin D. Kalyani, ’03 8 Cover story George C. -
NIH Grant Funds Search for Next-Generation Flu Vaccine September 20, 2019 | by Joanne Morrison Kathleen Neuzil, MD, MPH, Profe
NIH Grant Funds Search for Next-Generation Flu Vaccine Item Type Article Authors Morrison, Joanne Publication Date 2019-09-20 Keywords Neuzil, Kathleen; University of Maryland, Baltimore. Center for Vaccine Development and Global Health (CVD); Influenza Vaccines; Research Support, N.I.H., Extramural Rights Attribution-NonCommercial-NoDerivatives 4.0 International Download date 27/09/2021 14:45:05 Item License http://creativecommons.org/licenses/by-nc-nd/4.0/ Link to Item http://hdl.handle.net/10713/11027 NIH Grant Funds Search for Next-Generation Flu Vaccine September 20, 2019 | By Joanne Morrison Kathleen Neuzil, MD, MPH, professor of medicine and pediatrics and director of the Center for Vaccine Development and Global Health (CVD) at the University of Maryland School of Medicine (UMSOM), and UMSOM Dean E. Albert Reece, MD, PhD, MBA, announced that CVD has been awarded a contract from the National Institute of Allergy and Infectious Diseases (NIAID), with total funding of up to $200 million over seven years if all contract options are exercised. This research contract is one of the largest ever awarded to UMSOM and includes an initial award of approximately $2.5 million to conduct clinical testing of influenza vaccines. UMSOM Dean E. Albert Reece speaks as (l-r) Sen. Chris Van Hollen, Kathleen Neuzil, James Campbell, and Wilbur Chen listen. CVD’s research is aimed at testing improved seasonal influenza vaccines and conducting controlled human influenza challenge studies for NIAID's Collaborative Influenza Vaccine Innovation Center (CIVICs) program, which has the ultimate goal of developing a universal vaccine to protect against emerging influenza strains as well as improvements to current seasonal vaccines. -
The Power of Partnership
MEDICINE The Power of Partnership Annual 2017Report The Power of Partnership allows our two organizations to provide compassionate, discovery-based care and conduct the research and training that improve the health of the individuals and communities we serve. Lisa Shanahan needed a liver transplant, but her chances of getting one were slim. So her son, Colin Hambrook, 19, did some independent research and decided he would give her part of his own liver. The University of Maryland Medical Center is a nation- wide leader in performing living donor liver transplants. 2017 University of Maryland Medicine 2 A Shared Vision 4 Medical System Board of Directors 5 School of Medicine Board of Visitors The Power of Partnership 8 Advances in Transplantation 10 The Science of Sports 12 Family-Centered Intensive Care 14 Confronting a Public Health Crisis 16 Tackling Diabetes as a Team 18 A Magnet for Top Scientists 20 Breakthroughs in Neurological Care 22 The New Cancer Fighters 24 Bridging the Gap with Telehealth 26 The Greater Good: Healthier Communities 28 Extending our Reach 2017 Highlights 30 School of Medicine Highlights 40 Medical System Highlights 52 School of Medicine Financial Report 53 Medical System Financial Report 54 Leadership Contents 1 2017 University of Maryland Medicine The University of Maryland School of Medicine (UMSOM) and the University of Maryland Medical System (UMMS) share the vision that our partnership has the power to go beyond healing patients when they are sick. The power of our partnership extends to discovering new ways to prevent disease, as well as helping people stay healthy and manage their conditions, spending as little time as possible in the hospital — or staying out of it altogether.